Skip to main content
SpringerLink
Log in

Immunotherapy of cancer

A short review and commentary on current trials

  • Short Review
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Amery, W. K.: Immunopotentiation with levamisole in resectable bronchogenic carcinoma: A double blind controlled trial. Brit. Med. J. 3, 461 (1975)

    Google Scholar 

  2. Gutterman, J. U., Cardenas, J. O., Blumenschein, G. R.: Chemoimmunotherapy of remission and survival with BCG. Brit. Med. J. 2, 1222 (1976)

    CAS  PubMed  Google Scholar 

  3. Gutterman, J. U., Hersh, E., Benjamin, R., Mavligit, G., Burgess, M., Bodey, G.: An effective new chemoimmunotherapy regimen for disseminated malignant melanoma. Proc. Amer. Soc. Clin. Oncol. (Abstract C-135). In: Proc. Amer. Assoc. Cancer Res. 18, 300 (1977)

    Google Scholar 

  4. Gutterman, J. U., Mavligit, G., Gottlieb, J. A., Burgess, M. A., McBride, C. E., Einhorn, L., Freireich, E. J., Hersh, E. M.: Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus Calmette-Guerin. New Engl. J. Med. 291, 592–597 (1974)

    CAS  PubMed  Google Scholar 

  5. Gutterman, J. U., McBride, C. M., Freireich, E. J., Mavligit, G., Frei III, E., Hersh, E. M.: Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1, 1208 (1973)

    Google Scholar 

  6. Hortobagyi, G., Gutterman, J. U., Richman, S. P., Hersh, G. M.: Pseudomonas vaccine. A phase I evaluation for cancer immunotherapy. Cancer Treatment Reports (to be published)

  7. Houchens, D. P., Gaston, M. R., Kinney, Y., Goldin, A.: Prevention of cyclophosphamide (NSC-26271) immunosuppression by bacillus Calmette-Guerin. Cancer Chemother. Rep. 58, 931–933 (1974)

    Google Scholar 

  8. Israel, L.: Preliminary results of nonspecific immunotherapy for lung cancer. Cancer Chemother. Rep. (Part 3) 4, 283 (1973)

    Google Scholar 

  9. Kenady, D. E., Chretien, P. B., Potvin, C., Simon, R. M., Alexander, J. C., Goldstein, A. L.: Effect of thymosin in vitro on T-cell levels during radiation therapy. Cancer 39, 642 (1977)

    Google Scholar 

  10. LoBuglio, A. F., Neidhart, J. A., Hilberg, R. W., Metz, E. N., Balcerzak, S. P.: The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma. Cell. Immunol. 7, 159 (1973)

    Google Scholar 

  11. Mathé, G.: Introduction to Cancer Active Immunotherapy: Immunoprophylaxis and Immunorestoration. Berlin-Heidelberg-New York: Springer 1976

    Google Scholar 

  12. Mathé, G., Amiel, J. L., Schwarzenburg, L., Schneider, M., Catlan, A., Schlumberger, J. R., Hayat, M., Vassal, F. De: Active immunotherapy for acute lymphoid leukemia. Lancet 1, 697 (1969)

    Article  PubMed  Google Scholar 

  13. Mansell, P. W. A., DiLuzio, N. R., Hammer, C.: Macrophage activation in the treatment of cancer. Clin. Oncol. 3, 123 (1977)

    Google Scholar 

  14. Mavligit, G. M., Gutterman, J., Burgess, M. A., Khankhanian, N., Seibert, G. B., Speer, J. F., Jubert, A. V., Martin, R. C., McBride, C. M., Copeland, E. M., Gehan, E. A., Hersh, E. M.: Prolongation of postoperative disease-free interval and survival in human colorectal cancer by BCG or BCG plus 5-fluorouracil. Lancet 1, 871 (1976)

    Google Scholar 

  15. Mikulski, S., Muggia, F. M.: Biological activity of MER-BCG in experimental systems and preliminary clinical studies. Cancer Treat. Rev. 4, 103 (1977)

    Google Scholar 

  16. Moayeri, H., Sokal, J. E.: BCG immunotherapy in active disseminated malignant lymphoma: Inferiority of an intensive vaccination schedule. Proc. Amer. Soc. Clin. Oncol. (Abstract C-44). In: Proc. Amer. Assoc. Cancer Res. 18, 277 (1977)

    Google Scholar 

  17. Newlands, E. S., Oon, C. J., Roberts, J. T., Elliott, P., Mould, R. F., Topham, C., Madden, F. J. F., Newton, K. A., Westbury, G.: Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma. Brit. J. Cancer 34, 174 (1976)

    Google Scholar 

  18. Omura, G. A., Vogler, W. R., Lynn, M. J.: A controlled clinical trial of chemotherapy vs. BCG immunotherapy vs. no further therapy in remission maintenance of acute myelogenous leukemia. Proc. Amer. Soc. Clin. Oncol. (Abstract C-23). In: Proc. Amer. Assoc. Cancer Res. 18, 272 (1977)

    Google Scholar 

  19. Perloff, M., Holland, J. F., Lumb, G. J., Bekesi, J. G.: Effects of methanol extraction residue of Bacillus Calmette-Guerin in humans. Cancer Res. 37, 1191 (1977)

    Google Scholar 

  20. Plich, Y. F., Kern, D. H.: Induction of antitumor antibody production in vitro by immune RNA (Abstract 511). Proc. Amer. Assoc. Cancer Res. 18, 128 (1977)

    Google Scholar 

  21. Pouillart, P., Mathé, G., Palangie, T., Huguenin, P., Morin, P., Gautier, H., Baron, A., Lededente, A.: Postsurgery adjuvant immunotherapy of stage I and II, and pre-chemotherapy adjuvant immunotherapy of stage III and IV bronchus carcinoma. Proc. Amer. Soc. Clin. Oncol. (Abstract C-297). In: Proc. Amer. Assoc. Cancer Res. 18, 341 (1977)

    Google Scholar 

  22. Powles, R. L., Crowther, D., Bateman, C. J. T., Beard, M. E. J., MacElwain, T. J., Russell, J., Lister, T. A., Withehouse, J. M. A., Wrigley, P. F. M., Pike, M., Alexander, P., Hamilton-Fairley, G.: Immunotherapy for acute myelogenous leukemia. Brit. J. Cancer 28, 365 (1973)

    CAS  PubMed  Google Scholar 

  23. Rojas, A. F., Mickiewicz, E., Feierstein, J. N., Glait, H., Olivari, A. J.: Levamisole in advanced human breast cancer. Lancet 1, 211 (1976)

    Google Scholar 

  24. Sokal, J. E.: Immunotherapy of CML, 1965–74 (Abstract 255). Proc. Amer. Assoc. Cancer Res. 16, 64 (1975)

    Google Scholar 

  25. Sokal, J. E., Aungst, C. W., Snyderman, M.: Delay in progression of malignant lymphoma after BCG vaccination. N. Engl. J. Med. 291, 1226 (1974)

    CAS  PubMed  Google Scholar 

  26. Stewart, T. H. M., Hollinshead, A. C., Harris, J. E.: Immunochemotherapy of lung cancer. Proc. Amer. Soc. Clin. Oncol. (Abstract C-273). In: Proc. Amer. Assoc. Cancer Res. 17, 305 (1976)

    Google Scholar 

  27. Yamamura, Y., Azuma, I., Sugimura, K., Igarashi, T., Yamawaki, M., Kusumoto, S., Shiba, T.: Adjuvant and antitumor activities of synthetic cell wall peptidoglycan subunits. Proc. Jap. Cancer Assoc. 35th Ann. Mtg. (Abstract 215) 67 (1976)

  28. Yoshikumi, C.: Effect of PSK on recovery of immunologic responsiveness after administration of antitumor drugs or x-irradiation. Cancer and Chemotherapy (Japan) 2, 835 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland, USA

    Franco M. Muggia

Authors
  1. Franco M. Muggia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muggia, F.M. Immunotherapy of cancer. Cancer Immunol Immunother 3, 5–9 (1977). https://doi.org/10.1007/BF00199318

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199318

Keywords

Search

Navigation